BMP4 is a gene located on chromosome 14 that encodes the BMP4 protein, a key member of the Transforming Growth Factor Beta (TGF-β) family involved in various developmental processes. This protein plays a crucial role in bone formation, organ development, and metabolic regulation, with mutations in BMP4 leading to congenital conditions and potential complications such as vision problems, brain abnormalities, and bone malformations.
BMP4 is a gene that encodes the BMP4 protein.
The BMP4 gene is located on chromosome 14 and is responsible for producing the BMP4 protein, a key member of the Transforming Growth Factor Beta (TGF-β) family of signaling proteins.
This gene plays a critical role in various developmental processes, particularly in the formation of bone, eyes, brain, and hands.
Mutations in the BMP4 gene can result in significant developmental and structural problems. These mutations are associated with various congenital conditions, especially those affecting the eyes, brain, hands, and bones.
Eye-Related Issues:
Brain-Related Problems:
Hand and Finger Abnormalities:
Bone-Related Issues:
Gene interactions:
The BMP4 protein is an essential member of the Transforming Growth Factor Beta (TGF-β) superfamily and plays a vital role in multiple physiological processes. It is particularly involved in bone formation, organ development, fat cell differentiation, and several other functions.
Bone Growth and Repair:
Embryonic Development and Organ Formation:
In summary, the BMP4 gene and its protein product are central to many critical biological processes, including development, metabolism, bone growth, and even cancer progression.
Mutations in BMP4 can lead to various congenital disorders affecting the eyes, brain, hands, and bones and complicate disease conditions like FOP. BMP4's role in metabolism and its dual function in cancer make it a vital player in both health and disease.
BMP4 testing is primarily indicated for patients with developmental disorders or genetic conditions, as well as for those requiring monitoring for certain diseases.
It may be used in certain cancers, often to inform prognosis.
It may also be indicated as a screening tool in patients with a family history of BMP4-related genetic conditions.
The following section outlines the testing procedures and interpretation.
BMP4 genetic status is often assessed through blood tests. Special preparation is typically not required, although it’s always important to consult with the ordering provider beforehand. Some genetic assessments may recommend or require genetic counseling.
Sample collection generally occurs during routine follow-up visits or when specific clinical indications arise.
Normal reference ranges for BMP4 genetic testing are considered to be without mutations that can alter the activity of the BMP4 proteins.
The clinical implications of a positive BMP4 mutation test result will vary by individual, although BMP4 mutations in symptomatic patients signal an immediate need for further assessment and possibly treatment.
Patients or practitioners with questions about the clinical implications of BMP4 mutations should seek further assessment with a genetic counselor or expert.
Click here to compare genetic test panels and order genetic testing for health-related SNPs.
Baboota, R. K., Blüher, M., & Smith, U. (2021). Emerging Role of Bone Morphogenetic Protein 4 in Metabolic Disorders. Diabetes, 70(2), 303–312. https://doi.org/10.2337/db20-0884
Bakrania, P., Efthymiou, M., Klein, J. C., Salt, A., Bunyan, D. J., Wyatt, A., Ponting, C. P., Martin, A., Williams, S., Lindley, V., Gilmore, J., Restori, M., Robson, A. G., Neveu, M. M., Holder, G. E., Collin, J. R., Robinson, D. O., Farndon, P., Johansen-Berg, H., Gerrelli, D., … Ragge, N. K. (2008). Mutations in BMP4 cause eye, brain, and digit developmental anomalies: overlap between the BMP4 and hedgehog signaling pathways. American journal of human genetics, 82(2), 304–319. https://doi.org/10.1016/j.ajhg.2007.09.023
BMP4 bone morphogenetic protein 4 [Homo sapiens (human)] - Gene - NCBI. (n.d.). Www.ncbi.nlm.nih.gov. https://www.ncbi.nlm.nih.gov/gene/652
BMP4 Gene Sequence Analysis - Clinical test - NIH Genetic Testing Registry (GTR) - NCBI. (2021). Nih.gov. https://www.ncbi.nlm.nih.gov/gtr/tests/classic/595780/overview/
Emma-Leena Alarmo, Huhtala, H., Korhonen, T., Liisa Pylkkänen, Kaija Holli, Tuula Kuukasjärvi, Seppo Parkkila, & Kallioniemi, A. (2012). Bone morphogenetic protein 4 expression in multiple normal and tumor tissues reveals its importance beyond development. Modern Pathology, 26(1), 10–21. https://doi.org/10.1038/modpathol.2012.128
Entry - *112262 - BONE MORPHOGENETIC PROTEIN 4; BMP4 - OMIM. (2022). Omim.org. https://omim.org/entry/112262
Fernández-Sevilla, L. M., Valencia, J., Ortiz-Sánchez, P., Fraile-Ramos, A., Zuluaga, P., Jiménez, E., Sacedón, R., Martínez-Sánchez, M. V., Jazbec, J., Debeljak, M., Fedders, B., Stanulla, M., Schewe, D., Cario, G., Minguela, A., Ramírez, M., Varas, A., & Vicente, Á. (2022). High BMP4 expression in low/intermediate risk BCP-ALL identifies children with poor outcomes. Blood, 139(22), 3303–3313. https://doi.org/10.1182/blood.2021013506
Zhou, Y., Liu, Y., Zhang, J., Yu, D., Li, A., Song, H., Zhang, W., Davis, D., Gilbert, M. R., Liu, F., & Yang, C. (2020). Autocrine BMP4 Signaling Enhances Tumor Aggressiveness via Promoting Wnt/β-Catenin Signaling in IDH1-mutant Gliomas. Translational oncology, 13(2), 125–134. https://doi.org/10.1016/j.tranon.2019.10.019